Search for: "Acorda Therapeutics Inc."
Results 1 - 20
of 49
Sort by Relevance
|
Sort by Date
25 Mar 2022, 2:25 pm
Cir. 2015) (same); Acorda Therapeutics, Inc. v. [read post]
22 Jul 2021, 12:40 pm
See Acorda Therapeutics, Inc. v. [read post]
14 Jan 2020, 9:10 pm
.; Acorda Therapeutics, Inc. v. [read post]
8 Oct 2019, 9:44 am
Petitions Denied: A number of petitions that were pending last week have now been denied by the court: Acorda Therapeutics, Inc. v. [read post]
30 Sep 2019, 9:02 am
The court is scheduled to consider whether to grant certiorari in a number of important patent cases: Obviousness: Acorda Therapeutics, Inc. v. [read post]
19 Jun 2019, 6:18 am
Acorda Therapeutics, Inc. v. [read post]
15 Apr 2019, 6:09 am
Teva Pharmaceuticals USA Inc.: Allergan & SRMT Cert Petition Questions presented: Whether the Federal Circuit erred in this case, as it did in Acorda Therapeutics, Inc. v. [read post]
9 Apr 2019, 8:03 pm
by Dennis Crouch Acorda Therapeutics, Inc. [read post]
12 Sep 2018, 9:47 pm
By Kevin E. [read post]
10 Sep 2018, 10:17 am
Acorda Therapeutics, Inc. v.Roxane Labs., Inc., No. 1:14-cv-00882-LPS, 2017 WL1199767, at *3, *5 (Mar. 31, 2017) (Dist. [read post]
20 Sep 2017, 9:18 am
In the face of this conundrum, the court relied on the Federal Circuit’s recent decision in Acorda Therapeutics Inc. v. [read post]
1 Apr 2017, 5:11 pm
On March 31, 2017, Acorda had a press release which noted:Acorda Therapeutics, Inc. [read post]
15 Feb 2017, 1:44 pm
” Id.Our decision in Acorda Therapeutics Inc. v. [read post]
8 Feb 2017, 3:09 am
Acorda Therapeutics, et al., No. 16-360 (does an ANDA filing create nationwide specific jurisdiction?) [read post]
16 Jan 2017, 5:44 pm
Acorda Therapeutics, et al., No. 16-360 (does an ANDA filing create nationwide specific jurisdiction?) [read post]
19 Dec 2016, 9:20 am
Acorda Therapeutics, Inc., 823 F.3d 51 (2d Cir. 2016). [read post]
19 Dec 2016, 9:20 am
Acorda Therapeutics, Inc., 823 F.3d 51 (2d Cir. 2016). [read post]
16 Dec 2016, 12:55 pm
Acorda Therapeutics, Inc., 823 F.3d 51 (2d Cir. 2016), recently adopted that very standard, so there was no need to grant rehearing on this issue.SPD argued that Apotexcouldn’t be reconciled with the opinion here, but the panel found that any “tension” was “only a tension of emphasis, not content. [read post]
14 Nov 2016, 9:16 am
Acorda Therapeutics, et al., No. 16-360 (does an ANDA filing create nationwide specific jurisdiction?) [read post]
2 Nov 2016, 10:16 am
Acorda Therapeutics, Inc. [read post]
